[Therapeutic effect of recombinant human interleukin-11 on thrombocytopenia models induced by anti-platelet serum in guinea pigs].
To observe the effect of recombinant human interleukin-11 on the platelet counts and the CFU-Meg of the marrow cell culture. Thrombocytopenia models of guinea pigs were made by injecting subcutaneously anti-platelet serum. 200, 100, and 50 micrograms.kg-1 of rHuIL-11 increased the CFU-Meg of the marrow cell culture and the peripheral platelet, showing a significant difference from that of the control group (P < 0.05). rHuIL-11 has a significantly therapeutic effect on thrombocytopenia models induced by anti-platelet serum in guinea pigs.